Sclerosis (MS) is the most common disability in young adults that requires
early symptomatic treatment to prevent long-term disability. Among young
adults, MS is the most common central nerv-ous system (CNS) chronic
inflammatory illness that is characterized by demyelination in the CNS.
However, current disease-modifying treatments are not sufficiently effective
for preventing the variety of symptoms during the co